Trials / Completed
CompletedNCT05431803
Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China
Real-World Study of Lanreotide Autogel for the Treatment of Patients With Acromegaly in China
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 129 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to assess the one-year effectiveness and safety of LAN among patients with acromegaly in China in routine clinical practice. In addition, the study is designed to understand the real-world treatment patterns and outcomes of LAN among Chinese patients with acromegaly.
Conditions
Timeline
- Start date
- 2022-06-30
- Primary completion
- 2024-12-13
- Completion
- 2024-12-13
- First posted
- 2022-06-24
- Last updated
- 2025-01-31
Locations
12 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05431803. Inclusion in this directory is not an endorsement.